Helium-Hyperoxia and 6MWT Distance in COPD

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

We assessed the effect of altering inspired gas on the 6MWT distance in COPD. We hypothesized that HeO2 would improve walking distance and reduce shortness of breath compared to both RA and O2, and potentially improve quality of life for COPD patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Saskatchewan
• Collaborator: Nova Scotia Health Authority

Criteria

Inclusion Criteria:

• Exertional dyspnea

• Activity limitation

• COPD

Exclusion Criteria:

• Recent exacerbation (< 4 wks)

• Supplemental O2

• Significant cardiovascular/musculoskeletal abnormalities